Obigen Pharma Inc.

NT$58.00As of Sun 8 Nov 2026, 12:00 UTC
TPEx:7876Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (30.51%)
Biological Products, Except Diagnostic Substances
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap NT$6.219B
ROIC (18.55%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$55
(4.51%)
(8.68%)
Buy 8|2|1|3|1
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.65
0.69
0.68
0.73
13.05%
18.71%
4.74%
12.29%
RevenueNT$M
805.4
809.8
810.8
798.6
8.00%
7.24%
7.91%
0.43%
Peers (US$187.8M)
Cap (US$)
PE
222.5M
—
191.2M
61.34x
Capital
TTM
5Y
10Y
Leveragex
0.627
0.510
0.458
EBIT/Intx
0.566
0.071
0.070
Own earn%
57.90
(15.99)
(22.34)
Sh yield%
23.54
40.39
39.32
Owners
Insiders/Inst%
10.39
80.97
Short interest%
1.19
SBC / revenue%
1.99
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
18–23
$1 testx
—
Incr. ROIC%
4